Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.57 | N/A | +9.62% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.57 | N/A | +9.62% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to operational efficiency. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining operational efficiency.
Phibro Animal Health reported a positive surprise in EPS, but the stock fell by 1.35% following the earnings release. The lack of revenue data and guidance may have contributed to investor caution. Overall, while the EPS beat is a positive sign, the market reaction suggests uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BANK NOVA SCOTIA
Aug 26, 2025